Search Results - Vladislav Klyashtornyy
- Showing 1 - 1 results of 1
-
1
Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 to 75 years: A comparison of phase 2b and phase 3 clinical trial material by Archana Jastorff, Arangassery Rosemary Bastian, Nynke Ligtenberg, Vladislav Klyashtornyy, Benoît Callendret, Esther Heijnen
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book